Clinical Trial Update: Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pre-mixed insulin with a regimen of insulin glargine plus rapid-acting insulin in adults with type 2 diabetes completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Pre-mixed insulin
• Rapid-acting insulin

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED